https://biocross.es/la-agencia-europea-del-medicamento-recomienda-el-uso-de-leqembi-para-el-tratamiento-de-alzheimer-en-estadios-iniciales/ Biocross is a biotechnology company that seeks to improve the life expectancy and quality of life of individuals with neurodegenerative diseases through the design of innovative diagnostic systems. Thu, 29 Jan 2026 21:39:18 +0000 hourly 1 https://wordpress.org/?v=6.9.1